# US 6,726,906 B1 · Fat-binding polymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,906 B1
- Document ID: US6726906B1
- Status: Granted
- Kind: B1
- Application number: 09/721,310
- Filed: 2000-11-22
- Granted: 2004-04-27
- Earliest claimed: 1999-07-14
- Assignees: Genzyme Corporation
- Inventors: Thomas Jozefiak; Stephen Randall Holmes-Farley; W. Harry Mandeville, III; Chad Cori Huval; Venkata R. Garigapati; Keith K. Shackett; Danny Concagh
- Web page: https://patentgrep.com/patent/US6726906B1

## CPC

- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 31/785: Polymers containing nitrogen
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a method for treating obesity, a method for reducing the absorption of dietary fat, and a method for treating hypertriglyceridemia in a patient and to particular polymers for use in the methods or in a manufacture of a medicament. The methods comprise the step of orally administering to a mammal, such as a human, a therapeutically effective amount of one or more fat-binding polymers. The administration of the fat-binding polymer of the invention facilitates the removal of fat from the body prior to digestion, with minimal side effects and low toxicity. In a preferred embodiment, the one or more fat-binding polymers are administered in combination with one or more lipase inhibitors, for example, lipstatin and tetrahydrolipstatin.

## Claims

### Claim 1

A method of treating obesity in a mammal comprising the step of orally administering to the mammal an effective amount of a fat binding polymer, salt, or copolymer thereof, characterized by a repeat unit having the formula: (VIII)
in combination with at least one lipase inhibitor.

### Claim 2 (depends on 1)

The method of claim 1 wherein said lipase inhibitor is tetrahydrolipstatin.

### Claim 3 (depends on 1)

The method of claim 1 wherein Poly(N,N-di(2,3-dihydroxypropyl)allylamine)hydrochloride is orally administered to the mammal.

### Claim 4

A method for treating steatorrhea in a mammal comprising the step of orally administering to the mammal a therapeutic amount of a polymer characterized by a repeat unit having the formula:

### Claim 5

A method for treating hypertriglyceridemia in a mammal comprising the step of administering to the mammal a therapeutically effective amount of at least one lipase inhibitor and a polymer characterized by a combination of repeat units having the formula:

### Claim 6

A method for reducing the absorption of dietary fat in a mammal comprising the step of orally administering to the mammal a therapeutically effective amount of at least one lipase inhibitor and a polymer characterized by a combination of repeat units having the formula:

### Claim 7

A polymer, salt or copolymer thereof, characterized by a repeat unit having the formula:
